Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften Cells
22. November 2021 02:00 ET
|
Immunicum AB
Pressmeddelande22 november 2021 Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften CellsImmunicum AB (publ; IMMU.ST), ett biofarmaceutiskt företag fokuserat på svårbehandlade solida...
Immunicum Publishes DCP-001 Mechanism of Action in the Journal Cells
22. November 2021 02:00 ET
|
Immunicum AB
Press ReleaseStockholm, Sweden, November 22, 2021Immunicum Publishes DCP-001 Mechanism of Action in the Journal CellsImmunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on hard-to-treat...
Immunicum presenterar nya forskningsdata vid årsmötet för Society for Immunotherapy of Cancer (SITC)
09. November 2021 08:00 ET
|
Immunicum AB
PressmeddelandeStockholm, Sverige, 9 november 2021Immunicum presenterar nya forskningsdata vid årsmötet för Society for Immunotherapy of Cancer (SITC)Immunicum AB (publ; IMMU.ST), ett bioteknikföretag...
Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual Meeting
09. November 2021 08:00 ET
|
Immunicum AB
Press ReleaseStockholm, Sweden, November 9, 2021Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual MeetingImmunicum AB (publ; IMMU.ST), a biopharmaceutical...
Immunicum bjuder in till investerarmöte med bolagets VD
28. Oktober 2021 07:00 ET
|
Immunicum AB
Pressmeddelande 28 October 2021 Immunicum bjuder in till investerarmöte med bolagets VD Immunicum AB (publ; IMMU.ST) tillkännagav idag att bolaget måndagen den 15 november bjuder in till ett...
Immunicum to Host Investor Meeting with CEO
28. Oktober 2021 07:00 ET
|
Immunicum AB
Press Release 28 October 2021 Immunicum to Host Investor Meeting with CEO Immunicum AB (publ; IMMU.ST) today announced that on Monday, 15 November it will host an investor event providing the...
Immunicum presenterar data från det kliniska programmet DCP-001 vid European Hematology Association (EHA) 2021 Virtual Congress
11. Juni 2021 03:03 ET
|
Immunicum AB
Immunicum presenterar data från det kliniska programmet DCP-001 vid European Hematology Association (EHA) 2021 Virtual Congress - Den pågående ADVANCE-II-studien, som utvärderar DCP-001 hos...
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress
11. Juni 2021 03:03 ET
|
Immunicum AB
Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress -- Ongoing ADVANCE II study evaluating DCP-001 in AML patients is nearing...
IMMUNICUM AB (PUBL) JANUARI – MARS I SAMMANDRAG
04. Mai 2021 02:00 ET
|
Immunicum AB
Pressrelease 4 maj 2021 IMMUNICUM AB (PUBL) JANUARI – MARS I SAMMANDRAG Nettoomsättning för kvartalet uppgick till KSEK - (-) *.Periodens resultat uppgick till KSEK -41 571 (-12 018)...
Immunicum AB (publ) Interim Report January – March 2021
04. Mai 2021 02:00 ET
|
Immunicum AB
Press Release 4 May 2021 Immunicum AB (publ) Interim Report January – March 2021 JANUARY – MARCH IN SUMMARY Net sales for the period amounted to KSEK - (-)*.Result for the quarter amounted to...